Mira Pharmaceuticals 株価情報 (NASDAQ: MIRA)

最新ニュース Mira Pharmaceuticals (NASDAQ:MIRA) 株価情報

Mira Pharmaceuticals

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals Inc

MIRAI Corp

MIRAIT One Corp

MIRAMAR RESOURCES LTD by MIRAMAR RESOURCES LTD

MIRATI THERAPEUTICS INC COM

MIRACLE ENTMT INC by Miracle Entertainment Inc.

Miracle Entertainment Inc

MIRAGE ENERGY CORP by Mirage Energy Corporation

Mirage Energy Corp

MIRAMAR HOTE & INVST CO by Miramar Hotel & Investment Co., Ltd.

Miramar Hotel & Investment Co Ltd

TAKARA LEBEN CO LTD by Takara Leben Co., Ltd.

Mirarth Holdings Inc

MIRASOL RESOURCES LTD by Mirasol Resources Ltd.

Mirasol Resources Ltd

Miratap Inc

MIRAVANT MEDICAL TECHS by Miravant Medical Technologies

Miravant Medical Technologies

WIIM

Salesforce shares are trading lower after the company issued FY26 EPS guidance below estimates. Additionally, RBC Capital downgraded the stock from Outperform to Sector Perform and cut its price target from $420 to $275.

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 5.09% on an annualized basis producing an average annual return of 19.02%. Currently, Philip Morris Intl has a market capitalization of $274.10 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,386.50 today based on a price of $176.10 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748528119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Investor Kevin O&#8217;Leary, also known as "Mr. Wonderful" from &#8220;Shark Tank,&#8221; slammed the Trump administration's move to <a href="https://www.benzinga.com/25/05/45578777/trump-administration-revokes-harvards-ability-to-enroll-international-students-kristi-noem-alleges-coordination-with-chinese-communist-party">block Harvard University</a> from enrolling international students in a recent Fox Business <a href="https://www.youtube.com/watch?v=x8DTYnPz9-w">interview</a> with Stuart Varney.
<h2 class="wp-block-heading">O'Leary Defends Harvard's Global Talent</h2>
"These are the smartest students in the world," O'Leary, who teaches at Harvard Business School, told Fox Business. "They don't hate America. They want to stay in America, and we want them to be here."
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
He called on Harvard&#8217;s leadership to act fast: "The <a href="https://www.benzinga.com/news/25/04/44916659/harvard-sues-trump-administration-for-attempting-to-withhold-billions-in-federal-grants-over-alleged-antisemitism-response">president of Harvard</a> has to call the president of the United States, get behind closed doors and work out a deal."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It&#39;s so clear as to what has to happen. The president of Harvard has to call the president of the United States, get behind closed doors, and work out a deal. But let me assure you something about these international students. I teach them. These are the smartest students in the… <a href="https://t.co/tGh85xRbHQ">pic.twitter.com/tGh85xRbHQ</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1925959606787846225?ref_src=twsrc%5Etfw">May 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
O'Leary said he teaches many of these international students and considers them worth investing in. "When I go back to teach in the Fall, I, along with millions of investors, want them to stay in America," he told Varney.
O'Leary said the university's international students are a major asset. "Harvard is the oldest educational institution. These students are extraordinary individuals&#8230; We want them here, I want to invest in them. I&#8217;ve already invested in two of them."
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
<h2 class="wp-block-heading">Students Left in Legal Limbo</h2>
His comments come after the Trump administration moved to bar foreign enrollment at Harvard, sparking legal challenges and public backlash. A federal judge has temporarily blocked the move, but international students are still uncertain about their status.
Harvard student body co-president Abdullah Shahid Sial told <a href="https://edition.cnn.com/2025/05/23/world/harvard-international-students-trump-intl">CNN</a> the situation has created &#8220;pure panic&#8221; on campus. "They're literally like, teenagers, thousands of miles away from their hometowns having to deal with this situation, which lawyers often fear to engage in," said Sial, who is from Pakistan and is unsure if he'll be allowed back into the U.S.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
About 27% of Harvard's student body is made up of international students, which is in line with that of other Ivy League universities. Many now fear deportation, disrupted research, and being blocked from reentering the country.
"Many of us have worked our entire lives to get to a university like Harvard, and now we need to wait around and see if we might have to transfer out and face difficulties with visas," Karl Molden, a junior from Austria, told CNN.
Maria Kuznetsova, a graduate student from Russia, also told CNN she can't return home due to her past work in human rights. "I don't really know where I could even go geographically if things go wrong."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Kevin O'Leary Says International Students Are 'Extraordinary Individuals.' He Adds, 'They Don't Hate America, And I Want To Invest In Them'

NAMI

Jinxin Technology Shares Halted On Circuit Breaker To The Downside, Stock Now Down -32.4%

<a href="https://event.webcasts.com/viewer/event.jsp?ei=1719356&amp;tp_key=cd8650a795">https://event.webcasts.com/viewer/event.jsp?ei=1719356&amp;tp_key=cd8650a795</a>

General

Boeing CEO At Bernstein Conference Reportedly Says Chinese Airlines Going To Take Deliveries Of New Aircraft Starting In June; Says Getting Very Close To Achieving 38 Per Month Production Rate For 737 Max

DA Davidson analyst Michael Baker maintains Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) with a Buy and lowers the price target from $273 to $230.

Price Target

Analyst Ratings

DA Davidson Maintains Buy on Dick's Sporting Goods, Lowers Price Target to $230

Shares of Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) rose 0.74% to $113.67 early Thursday, moving in tandem with Nvidia Corp, which jumped nearly 6% following a standout earnings report. Nvidia's first-quarter results exceeded expectations, driven by surging demand for its data center and AI-related products.
What To Know: Nvidia <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45668727/nvidia-stock-is-surging-thursday-whats-fueling-the-move">posted</a> first-quarter revenue of $44.1 billion, up 69% year-over-year and ahead of Wall Street's $43.2 billion estimate. Adjusted earnings per share came in at 96 cents, excluding a $4.5 billion charge related to U.S. export restrictions on China-bound H20 chips. Data center revenue soared 73% to $39.1 billion, while gaming and AI PC revenue jumped 42%.
Despite losing $8 billion in potential second-quarter revenue due to export controls, Nvidia still guided for second-quarter revenue of $45 billion, underscoring continued strength in global <a href="https://www.benzinga.com/25/05/45662144/despite-8-billion-blow-from-china-export-curbs-nvidia-still-raised-guidance-as-blackwell-chips-and-enterprise-ai-demand-soar-highlights-four-explosive-growth-drivers">AI demand</a>. Analysts responded positively, with several reiterating Buy ratings and raising price targets as high as $200.
AMD shares climbed alongside Nvidia, as investors bet on continued momentum across the semiconductor sector, especially amid global investments in <a href="https://www.benzinga.com/news/earnings/25/05/45657660/nvidia-q1-highlights-china-export-ban-hits-results-but-jensen-huang-says-demand-incredibly-strong">AI infrastructure</a>. Reports of Japan planning to import $7 billion in U.S. chips also boosted sentiment for AMD and peers.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/05/45669445/us-economy-contracts-by-02-in-q1-labor-market-shows-signs-of-cracks-as-jobless-claims-surge">US Economy Contracts By 0.2% In Q1, Labor Market Shows Signs Of Cracks As Jobless Claims Surge</a>
<h2 class="wp-block-heading">How To Buy AMD Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Advanced Micro Devices&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AMD has a 52-week high of $187.28 and a 52-week low of $76.48.

AMD Stock Rises On Nvidia's Blowout Quarter And AI Momentum

DA Davidson analyst Thomas Diffely maintains Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) with a Buy and lowers the price target from $35 to $30.

PLAB

DA Davidson Maintains Buy on Photronics, Lowers Price Target to $30

U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) rose sharply during Thursday's session <a href="https://in.benzinga.com/trading-ideas/movers/25/05/45668750/why-veeva-systems-stock-is-gaining-today">following strong quarterly results.</a>
The company reported adjusted earnings per share of $1.97, beating the analyst consensus estimate of $1.77. Quarterly sales of $759 million (+17% year over year) outpaced the Street view of $731.91 million.
For the full fiscal year ending January 31, 2026, the company projects total revenue between $3.09 billion and $3.10 billion versus the Street view of $3.09 billion (prior view: $3.040 billion to $3.055 billion), non-GAAP operating income of approximately $1.36 billion, and adjusted diluted EPS of around $7.63 versus the Street view of $7.56 (Prior view: $7.32).
Veeva Systems shares jumped 19.9% to $281.10 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>ORIC Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) shares jumped 32% to $7.88 after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) gained 28.2% to $25.01.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) jumped 27% to $114.92 after the company reported better-than-expected quarterly results and announced it will acquire Rhode.</li>
<li>C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) gained 26.7% to $29.22 after the company reported better-than-expected fourth-quarter financial results and announced a renewal and expansion of its joint venture with Baker Hughes for accelerated AI-driven transformations in the energy and industrial sectors.</li>
<li>Claritev Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTEV#NYSE">CTEV</a>) gained 23.6% to $32.96.</li>
<li>SS Innovations International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) rose 19.5% to $6.07.</li>
<li>BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) gained 12.1% to $40.28 after the company reported better-than-expected quarterly financial results. Additionally, the company announced that its president, CEO, and chair of the board will retire by the end of the fiscal year.</li>
<li>Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) rose 9.3% to $213.89 following upbeat quarterly results.</li>
<li>CoreWeave, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) gained 6% to $122.78.</li>
<li>Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) rose 4.3% to $115.69 following strong quarterly results.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

CRWV

CTEV

DOOO

LZMH

NDSN

ORIC

SSII

VEEV

Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday

Boeing CEO During Bernstein Conference Reportedly Says Going To Be In A Dynamic Environment For A While Here Until Some Of Unilateral Agreements Are Put In Place

DA Davidson analyst Gil Luria maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Underperform and raises the price target from $200 to $225.

DA Davidson Maintains Underperform on Salesforce, Raises Price Target to $225

Bitget aims to become &#8220;the first billion user company&#8221; in crypto within two years by focusing <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45667896/hedera-co-founder-predicts-that-everything-of-value-will-be-tokenized">on everyday payments</a> rather than trading, according to Chief Operating Officer Vugar Usi.
What Happened: Usi told Benzinga during an interview at Consensus 2025 that to have a billion users in crypto, the industry should not focus on traders. 
&#8220;Billion people will never trade, but what a billion person wants to do is buy a coffee with crypto, hold their money in crypto, actually own their money,&#8221; Usi explained, emphasizing that Bitget&#8217;s vision centers on financial autonomy rather than speculation.
The exchange currently serves 100 million customers, making it &#8220;the second largest crypto exchange by the number of users,&#8221; with approximately $20 billion in daily trading volume. 
This represents significant growth, as Usi noted the company has expanded &#8220;10 times&#8221; over the past two years and &#8220;five times in terms of number of users&#8221; last year alone.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45651580/want-to-earn-yield-on-your-bitcoin-heres-how">Want To Earn Yield On Your Bitcoin? Here&#8217;s How</a>
Why It Matters: Bitget&#8217;s strategy involves bridging centralized and decentralized finance through its wallet product, which Usi claims has surpassed both MetaMask and Trust Wallet to become &#8220;the biggest trading and most loved trading wallet&#8221; with 60 million customers and $12 billion in daily volume. 
The company invested $30 million to build this decentralized wallet during the bear market three years ago when &#8220;literally everyone in the industry thought we are crazy,&#8221; according to Usi.
The COO believes crypto payments will revolutionize commerce by eliminating intermediaries and reducing costs for merchants. 
&#8220;Instead of paying 3% for bank card processors and waiting 15-20 days to receive their money, it will happen instantaneously, which will boost the economy, boost the businesses, and make crypto an everyday thing,&#8221; he stated.
When asked about skeptics, Usi compared crypto adoption to previous technological shifts that seemed unnecessary until they became indispensable. 
&#8220;If 10-15 years ago someone told us that we will have a phone and we&#8217;re going to use Apple Pay to pay something, people would have thought you are crazy,&#8221; he said, adding that &#8220;technology makes our life so much easier&#8221; once people adapt to it.
Looking ahead, Usi predicts significant industry convergence: &#8220;In next 5 years, almost all banks will become centralized exchanges,&#8221; noting that major financial players have &#8220;understood that crypto is undeniable the future.&#8221; 
He envisions a world where users won&#8217;t distinguish between on-chain and off-chain transactions, similar to how people use payment cards today without understanding the underlying technology.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45646680/trump-familys-expanding-crypto-ties-raise-questions-on-ethics-influence-and-investor-risk">Trump Family&#8217;s Expanding Crypto Ties Raise Questions On Ethics, Influence, And Investor Risk</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

Interview

Bitget's Billion-User Bet: Can Crypto Go From Trading Floors To Coffee Shops?

DA Davidson analyst Rudy Kessinger maintains SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) with a Neutral and lowers the price target from $18 to $17.

DA Davidson Maintains Neutral on SentinelOne, Lowers Price Target to $17

<a href="https://www.bloomberg.com/news/articles/2025-05-29/amazon-owned-blink-debuts-70-doorbell-cam-with-wider-view-person-detection?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-29/amazon-owned-blink-debuts-70-doorbell-cam-with-wider-view-person-detection?embedded-checkout=true</a>

AMZN

'Amazon-Owned Blink Debuts Doorbell Cam With Wider View, Person Detection'- Bloomberg

DA Davidson analyst Gil Luria maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Neutral and raises the price target from $120 to $135.

NVDA

DA Davidson Maintains Neutral on NVIDIA, Raises Price Target to $135

MATV

Mativ Holdings Receives First Purchase Order For Materials Used In Miru's Dynamic Electrochromic Window Technology From A Major Glass Manufacturer

DA Davidson analyst Tom White maintains Tripadvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) with a Neutral and raises the price target from $16 to $16.25.

TRIP

DA Davidson Maintains Neutral on Tripadvisor, Raises Price Target to $16.25

QUBT

QUBT stock has given up its prior gain. Quantum Computing shares were trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes on June 30.

Darling Ingredients Announces Dual Listing Of Its Common Stock On NYSE Texas; To Trade Under 'DAR' On NYSE Texas

<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="896" height="504" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075650/Shipping.jpg" alt="" class="wp-image-13570" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075650/Shipping.jpg 896w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075650/Shipping-300x169.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075650/Shipping-768x432.jpg 768w" sizes="(max-width: 896px) 100vw, 896px" /></figure>
<h2 class="wp-block-heading">Why the International Trade Court's Tariff Ruling Could Spark a Shipping Rally</h2>
<h2 class="wp-block-heading">1. The ruling Wall Street called a "nothingburger"</h2>
On May 28, 2025, the U.S. Court of International Trade (CIT) struck down President Trump's 10 percent post‑Liberation Day tariffs on consumer goods. Goldman Sachs dismissed the decision as a nothingburger, arguing the White House can simply re‑impose duties under other statutes. 
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading">2. Why it's&nbsp;not&nbsp;a nothingburger</h2>
Yes, the president still has tariff levers—but none are instantaneous:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<th>Backup authority</th>
<th>Maximum duty &amp; duration</th>
<th>Procedural steps</th>
<th>Realistic timeline</th>
</tr>
<tr>
<td>Trade Act § 122&nbsp;(balance‑of‑payments)</td>
<td>15% for 150&nbsp;days</td>
<td>Publish finding of large BOP deficit; draft tariff schedule; Federal Register notice</td>
<td>Weeks</td>
</tr>
<tr>
<td>Section&nbsp;301&nbsp;(unfair trade)</td>
<td>Unlimited</td>
<td>Launch or revive USTR investigation; public comment</td>
<td>Months</td>
</tr>
<tr>
<td>Section&nbsp;232&nbsp;(national security)</td>
<td>Unlimited</td>
<td>Commerce study (270&nbsp;days) + presidential decision</td>
<td>~1&nbsp;year</td>
</tr>
</tbody>
</table>
</figure>
Even a two‑week gap is plenty for importers to front‑load orders, driving spot freight rates up before new duties kick in.
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading">3. What a tariff pause does to trade</h2>
<ul class="wp-block-list">
<li>Booking surge:&nbsp;During the 90‑day China ceasefire earlier this year, Asia‑U.S. bookings&nbsp;tripled&nbsp;in the first week.</li>
<li>Spot rate pop:&nbsp;Asia‑US freight indices typically jump 10–15&nbsp;percent overnight when volumes spike.</li>
<li>Equity beta:&nbsp;Container‑liner shares tend to move 2–3× the broader transport index on tariff headlines.</li>
</ul>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading">4. Meet&nbsp;ZIM Integrated Shipping&nbsp;(NYSE:&nbsp;ZIM)</h2>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Metric</td>
<td>Snapshot</td>
</tr>
<tr>
<td>Headquarters</td>
<td>Haifa, Israel (global network of 147 ships)</td>
</tr>
<tr>
<td>Business model</td>
<td>Asset‑light: 117 vessels chartered, giving route flexibility</td>
</tr>
<tr>
<td>Trade‑lane mix</td>
<td>~43 % of volume—and 55 % of revenue—from Pacific services</td>
</tr>
<tr>
<td>Fleet upgrade</td>
<td>28 LNG dual‑fuel ships in service (final unit delivered Jan 2025), cutting fuel burn 20–25 %; 10 additional 11,500 TEU LNG vessels on order for 2027‑28 delivery</td>
</tr>
<tr>
<td>Financials</td>
<td>Q1 2025 EBIT $463 M; liquidity $2.25 B; net leverage 2.8 ×; Piotroski F-Score: 8 (on 0-9 scale; excellent)</td>
</tr>
</tbody>
</table>
</figure>
We entered a trade on ZIM Integrated Shipping Services, Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) earlier this month in the Portfolio Armor trading Substack.
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/p/trade-alert-top-names-bullwhip-effect"><img loading="lazy" decoding="async" width="737" height="746" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075804/Trade-Alert-3.jpg" alt="" class="wp-image-13572" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075804/Trade-Alert-3.jpg 737w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075804/Trade-Alert-3-296x300.jpg 296w" sizes="(max-width: 737px) 100vw, 737px" /></a></figure>
Think of ZIM as a nimble specialist in the lanes most sensitive to U.S.–Asia trade policy, one that&#8217;s now running a cleaner, cheaper fleet than many legacy rivals.
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading">5. Why ZIM stands to gain from a tariff hiatus</h2>
<ul class="wp-block-list">
<li>Heavy Pacific exposure:&nbsp;More than half its revenue is tied to Trans‑Pacific routes—the first to rebound when tariffs ease.</li>
<li>Charter agility:&nbsp;Because ZIM charters most ships, it can redeploy capacity quickly to the highest‑yield trades.</li>
<li>Cost leverage:&nbsp;New LNG ships lower per‑box fuel costs, widening margins as spot rates climb.</li>
<li>Fresh comeback:&nbsp;After a tough 2024, ZIM is already profitable again; incremental volume flows straight to the bottom line.</li>
</ul>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading">6. Risks to monitor</h2>
<ol start="1" class="wp-block-list">
<li>Fast‑track §&nbsp;122 tariffs:&nbsp;If the White House publishes a new schedule within a month, the rally could fade by late summer.</li>
<li>China‑specific duties:&nbsp;A narrower tariff could hurt Pacific lanes again while sparing Atlantic trades.</li>
<li>Charter cost inflation:&nbsp;ZIM's asset‑light model also means it pays higher daily rates if ship owners regain pricing power.</li>
<li>Regional security threats:&nbsp;Israel's current conflict with Yemen‑based Houthi militants could potentially lead to disruptions to ZIM's Haifa headquarters or eastern‑Mediterranean operations.</li>
<li>If you want to hedge those risks: The Portfolio Armor iPhone app can help you find the optimal hedge given your time frame and risk tolerance. You can download it by aiming your iPhone camera at the QR code below (or tapping&nbsp;<a href="https://apps.apple.com/us/app/portfolio-armor/id394951144" target="_blank" rel="noreferrer noopener">here</a>, if you're reading this on your iPhone).</li>
</ol>
<figure class="wp-block-image size-large"><a href="https://apps.apple.com/us/app/portfolio-armor/id394951144"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075925/PA-JPEG-8-1024x683.jpeg" alt="" class="wp-image-13573" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075925/PA-JPEG-8-1024x683.jpeg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075925/PA-JPEG-8-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075925/PA-JPEG-8-768x512.jpeg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29075925/PA-JPEG-8.jpeg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h2 class="wp-block-heading">7. The bottom line</h2>
The CIT decision likely delivers at least a short tariff hiatus—more than enough for a burst of U.S. import demand and a spike in Trans‑Pacific spot rates. Among listed container carriers,&nbsp;ZIM offers some of the purest exposure to that tailwind, backed by an increasingly efficient fleet and fresh profitability.&nbsp;
If you want a heads up when we place our next trade, feel free to sign up for our trading Substack/occasional email list below.&nbsp;
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="581" height="372" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29080042/Widget-7.jpg" alt="" class="wp-image-13574" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29080042/Widget-7.jpg 581w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/29080042/Widget-7-300x192.jpg 300w" sizes="(max-width: 581px) 100vw, 581px" /></a></figure>

Equities

Technicals

Options

Opinion

Signals

A Shipping Stock Poised To Benefit From Court-Imposed Tariff Pause

Press Releases

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Neuropathic Pain

MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain

MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million Capital Infusion to Advance Weight Loss and Smoking Cessation Drug Development

MIRA Pharmaceuticals Enrolls First Subjects in Phase 1 Clinical Trial of Ketamir-2 for Neuropathic Pain

MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion

MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation

MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity

MIRA Pharmaceuticals Announces Board Approval of SKNY Acquisition Reflecting $60+ Million in Combined Enterprise Value Based on Independent Review

MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program

MIRA

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Gelteq

Grace Therapeutics

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

ProPhase Labs

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Scilex Holding

SCYNEXIS

TherapeuticsMD

VYNE Therapeutics

Rodman & Renshaw

Ascendiant Capital

Screenshot 2024-10-02 at 5.44.40 PM

Biotech

Breakthrough Therapies And Novel Treatments - This Biopharma Is Out To Change The Game

Screenshot 2024-09-18 at 6.27.57 PM

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025

Screenshot 2024-09-04 at 6.19.41 PM

TELO

Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs

Screenshot 2024-08-26 at 4.53.37 PM

The Potential Of Ketamir-2: A Safer Treatment For Mental Health Disorders And Neuropathic Pain, IND Filing Expected By Year-End

Screenshot 2024-07-25 at 6.08.16 PM

MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year

Comments

Mira Pharmaceuticals

ニュース

最新ニュース Mira Pharmaceuticals (NASDAQ:MIRA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル